Drug Discovery, Development and Delivery
A section of Biomedicines (ISSN 2227-9059).
Section Information
This Section publishes original and innovative scientific papers, as well as comprehensive review papers. It is organized into topics mainly covering drug discovery, drug design, basic and clinical pharmacology, formulation and delivery, and toxicology.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Drug Discovery and Development Using Mass Spectrometry (Deadline: 31 May 2026)
- Poly-Pharmacological Effects and Mechanisms of Phytochemicals (Deadline: 31 May 2026)
- Activation of Apoptosis Pathways by Drugs: Innovative Strategies for Targeted Cancer Therapy (Deadline: 31 May 2026)
- Advanced Research in Anticancer Inhibitors and Targeted Therapy (Deadline: 31 May 2026)
- Innovative Drug Target Discovery in Cancer: From Molecular Mechanisms to Therapeutic Targets (Deadline: 31 May 2026)
- Advances in Drug Discovery and Development: From Rational Design to Experimental Validation (Deadline: 31 May 2026)
- Advances in Novel Drug Discovery, Synthesis, and Evaluation (Deadline: 30 June 2026)
- Drug Development in Gastrointestinal Disorders (Deadline: 30 June 2026)
- Nano-Mediated Drug Delivery (Deadline: 30 June 2026)
- Targeted Nanomedicine: From Design to Application (Deadline: 30 June 2026)
- Advances in Pharmacology of Pain and Inflammation (Deadline: 30 June 2026)
- Antipsychotics: 70 Years—2nd Edition (Deadline: 30 June 2026)
- The Preparation of an Exosome/Liposomal Nano-Drug Delivery System and Its Application in the Treatment of Inflammatory Bowel Disease (Deadline: 30 June 2026)
- Advancing Pharmacogenetics and Pharmacogenomics in Pre-Clinical Research: Unveiling New Avenues for Precision Medicine (Deadline: 30 July 2026)
- The Latest Advancements in Tumor Drug Delivery Systems (Deadline: 31 July 2026)
- Emerging Strategies in Targeted and Smart Drug Delivery (Deadline: 31 July 2026)
- Advances in Heart Failure Pharmacotherapy (Deadline: 31 July 2026)
- Natural Products in Cancer Research: From Traditional Medicine to Modern Drugs (Deadline: 31 July 2026)
- Structure-Based Drug Molecule Design and Organic Synthesis (Deadline: 31 July 2026)
- Nanoparticles for Glioblastoma Therapy (Deadline: 31 August 2026)
- Drug Discovery of Novel Anti-Inflammatory Compounds, Their Molecular Targets, and Translational Advancements (Deadline: 31 August 2026)
- Exploring Bioactive Metabolites and Immunomodulatory Potential in Natural Products (Deadline: 31 August 2026)
- Innovative Anticancer Agents: Design, Synthesis and Pharmacological Evaluation (Deadline: 31 August 2026)
- Natural Product for the Interventions of Chronic Diseases: From Source to Therapy—2nd Edition (Deadline: 30 September 2026)
- Novel Drug Delivery Systems: Design, Evaluation and Application: 2nd Edition (Deadline: 30 October 2026)
- "Small Molecule Inhibitors" in Biomedicines (Deadline: 30 October 2026)
- Research Progress on Antimicrobial Resistance (AMR) (Deadline: 30 October 2026)
- Medicinal Cannabis: Advances in Therapeutics and Clinical Applications (Deadline: 31 October 2026)
- Pharmacogenetics and Pharmacogenomics: Driving Forces in Modern Precision Medicine (Deadline: 31 October 2026)
- Drug Design via Structure–Activity Relationships (Deadline: 31 October 2026)
- Small Molecules, from Natural Sources, in Drug Discovery (Deadline: 31 October 2026)
- Cannabinoids in Therapeutics: Mechanisms, Signaling Pathways and Personalized Treatment Strategies (Deadline: 31 October 2026)
- Current Challenges and Future Perspectives of Antimicrobial Therapy (Deadline: 31 October 2026)
- Natural and Synthetic Molecules with Anticancer Activity: Pharmacological Basis and Mechanistic Insight—2nd Edition (Deadline: 30 November 2026)
- Precision Medicine Through Functional Drug Screening and Disease Modeling (Deadline: 30 November 2026)
- Cancer Pharmacology (Deadline: 30 November 2026)
- State-of-the-Art Drug Discovery and Development in Poland (3rd Edition) (Deadline: 30 November 2026)
- Advanced Research in Drug Metabolism and Drug Transport (Deadline: 30 November 2026)
- Natural Products and Their Pharmacological Activity (Deadline: 30 November 2026)
- Integrating Multimodal Data, Artificial Intelligence, and Bioinformatics for Precision Medicine and Drug Development (Deadline: 30 November 2026)
- Drug Discovery, Development and Delivery: Current Status and Future Perspectives (Deadline: 31 December 2026)
- New Horizons in Enzyme Inhibitor Discovery: Targets, Design and Evaluation—2nd Edition (Deadline: 31 December 2026)
- Compounds from Natural Products as Sources for Drug Discovery—2nd Edition (Deadline: 31 December 2026)
- New Therapeutic Applications and Technology Development for Antibody–Drug Conjugates (Deadline: 31 December 2026)
- Peptide Drugs Discovery: From Design to Optimization (Deadline: 31 December 2026)
- Medicinal Chemistry in Drug Design and Discovery, 2nd Edition (Deadline: 31 January 2027)
- Anti-Cancer Agents: Synthesis and Evaluation of Pharmacological Activity (Deadline: 28 February 2027)
Topical Collection
Following topical collection within this section is currently open for submissions:
